Full article on TAS-102.
"A phase III trial to test TAS-102 in a large colorectal cancer population is already underway, scheduled to be completed by the end of 2014. The international RECOURSE phase III clinical trial began in June of this year. The trial is randomizing approximately 800 advanced, recurrent colorectal cancer patients to either a twice-daily dose of TAS-102 or placebo. All patients have colorectal cancer that is refractory to chemotherapies including irinotecan, fluoropyrimidines, and oxaliplatin, or EGFR antibodies if the patient has KRAS-positive colorectal cancer. The trial will compare TAS-102 to best supportive care for these patients."
It's certainly not "The Cure" but it can hopefully provide another options for those who choose it.
*This is a Clinical Trial, there are stats which state: "Patients in the TAS-102 arm had a median overall survival of 9 months compared to 6.6 months in the placebo group" and other lovely numbers. If most of us were to look back at our initial prognosis, we all were probably told we'd be dead by now.
Anyone reading this (most likely) isn't dead.